产品说明
一般描述
With formulation challenges in mind, we have used particle engineering technologies to develop functional excipients specifically for solid oral dosage forms. The products in our Parteck® portfolio feature unique particle properties tailored for excellent performance in tableting processes, for specific drug delivery technologies, or for solubility enhancement.
As part of our Emprove® Program, our raw materials are offered with extensive documentation facilitating compliance of your pharma and biopharma product, full supply chain transparency and risk mitigation. Our SAFC® portfolio of high-quality products for biopharmaceutical and pharmaceutical formulation and production withstands strict quality control procedures and is produced according to applicable cGMP guidelines.
应用
Parteck® PLX 188 excipient combines adequate lubrication at tolerable concentrations with the added benefit of dissolution enhancement. It features consistent performance, improved dissolution rate and reliable lubrication – all at the same time. As a result, Parteck® PLX 188 excipient can therefore provide a simple solution to low bioavailability of DCS 2a compounds.
法律信息
Emprove is a registered trademark of Merck KGaA, Darmstadt, Germany
PARTECK is a registered trademark of Merck KGaA, Darmstadt, Germany
SAFC is a registered trademark of Merck KGaA, Darmstadt, Germany
基本信息
线性分子式 | (C3H6O · C2H4O)x |
MDL编号 | MFCD00082049 |
产品性质
质量水平 | 500 |
生物来源 | synthetic |
机构 | NF Ph. Eur. |
产品线 | EMPROVE® ESSENTIAL |
bp | >150 ℃ |
mp | 55 ℃ |
堆积密度 | 1050 kg/m3 |
储存温度 | 2-25℃ |
InChI | 1S/C3H6O.C2H4O/c1-3-2-4-3;1-2-3-1/h3H,2H2,1H3;1-2H2 |
InChI key | RVGRUAULSDPKGF-UHFFFAOYSA-N |
安全信息
储存分类代码 | 10 - Combustible liquids |
WGK | WGK 1 |
闪点(F) | Not applicable |
闪点(C) | Not applicable |